This study is collecting blood and other samples from people with cancer, including prostate, breast, colon, lung, and liver cancer, as well as healthy volunteers. Researchers want to understand how cancer affects the body's immune system and to find new ways to detect and treat cancer. They will analyze samples like blood, urine, saliva, and stool to look at genetic information and different types of cells. This study does not involve any treatment. You would have about 50 ml (3 tablespoonfuls) of blood drawn, and potentially more if you join a separate treatment study. The goal is to connect these lab findings with information about your health and treatment results.

Study design

This is an observational study planning to enroll 1750 participants. It is not testing a specific treatment, but rather collecting information and samples.

What's involved

You would have about 50 ml of blood drawn. If you participate in a separate treatment study, additional 40-ml blood samples may be drawn during treatment.

Compensation

Not stated in the trial record.

Follow-up

The genetic analysis and correlation with clinical parameters are measured on an ongoing basis.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.